Empiric Antibiotics for Acute Infectious Colitis
For most cases of acute infectious colitis, empiric antibiotics are NOT routinely recommended unless specific high-risk features are present. The decision to treat empirically depends critically on clinical severity, patient risk factors, and epidemiologic context.
When to Withhold Empiric Antibiotics
Do not treat empirically in immunocompetent patients with bloody diarrhea while awaiting diagnostic results, except in specific circumstances outlined below 1. Most infectious colitis cases are self-limited and resolve with supportive care alone 2.
Critical Exception: STEC Infections
- Avoid antibiotics entirely when Shiga toxin-producing E. coli (STEC) O157 or other Shiga toxin 2-producing strains are suspected or confirmed 1
- Antibiotics increase the risk of hemolytic uremic syndrome in these infections 1
- Suspect STEC when patients present with acute dysentery but have low-grade or absent fever 3
When Empiric Treatment IS Indicated
High-Risk Populations Requiring Empiric Therapy 1:
1. Infants <3 months of age with suspected bacterial etiology 1
2. Patients with bacillary dysentery syndrome:
- Frequent scant bloody stools
- Documented fever in medical setting
- Severe abdominal cramps and tenesmus
- Presumptively due to Shigella 1
3. Recent international travelers with:
- Body temperature ≥38.5°C AND/OR
- Signs of sepsis 1
4. Immunocompromised patients with severe illness and bloody diarrhea 1
5. Suspected enteric fever with clinical features of sepsis 1
Recommended Empiric Regimens
For Adults 1, 3:
First-line options (choose based on local resistance patterns and travel history):
- Azithromycin 1000 mg single dose (preferred for travel-related diarrhea or areas with fluoroquinolone resistance) 3
- Ciprofloxacin 500 mg twice daily (if local susceptibility permits) 1
The choice between these agents should account for:
- Increasing fluoroquinolone resistance in Campylobacter and Salmonella globally 2
- Travel history (Southeast Asia has particularly high fluoroquinolone resistance) 1
- Local antibiogram data 1
For Children 1:
Infants <3 months or those with neurologic involvement:
- Third-generation cephalosporin (ceftriaxone or cefotaxime) 1
Older children:
- Azithromycin (dose based on local susceptibility and travel history) 1
For Severe β-lactam Allergies:
- Azithromycin as alternative 1
Special Considerations
C. difficile Infection (CDI)
If CDI is suspected (recent antibiotic exposure, healthcare-associated diarrhea):
Initial episode, non-severe:
- Vancomycin 125 mg orally four times daily for 10 days OR
- Fidaxomicin 200 mg twice daily for 10 days 4
- These are strongly preferred over metronidazole 4
Initial episode, severe (WBC ≥15,000/mL or creatinine >1.5 mg/dL):
- Vancomycin 125 mg orally four times daily for 10 days OR
- Fidaxomicin 200 mg twice daily for 10 days 4
Fulminant CDI (hypotension, shock, ileus, megacolon):
- Vancomycin 500 mg orally four times daily 4
- PLUS metronidazole 500 mg IV every 8 hours 4
- If ileus present, add vancomycin 500 mg per rectum every 6 hours 4
Key Management Principles
Discontinue inciting antibiotics immediately when possible, as this influences recurrence risk 4
Avoid antiperistaltic agents and opiates in all forms of infectious colitis, particularly STEC and CDI 5
Obtain stool cultures before initiating therapy in high-risk patients to guide subsequent management 1
Narrow antibiotic spectrum once culture and susceptibility results become available 5
Common Pitfalls to Avoid
- Never treat asymptomatic contacts of patients with bloody diarrhea empirically 1
- Do not use fluoroquinolones empirically in areas with known high resistance rates without culture confirmation 2
- Avoid repeated or prolonged metronidazole courses due to cumulative neurotoxicity risk 4
- Do not delay surgical consultation in fulminant CDI or toxic megacolon 5